Behandling af neuroendokrine gastrointestinale tumorer
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Behandling af neuroendokrine gastrointestinale tumorer. / Hansen, Carsten Palnaes; Langer, Seppo; Frevert, Susanne; Mortensen, Jann; Kjær, Andreas; Knigge, Ulrich.
In: Ugeskrift for Laeger, Vol. 172, No. 43, 25.10.2010, p. 2942-5.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Behandling af neuroendokrine gastrointestinale tumorer
AU - Hansen, Carsten Palnaes
AU - Langer, Seppo
AU - Frevert, Susanne
AU - Mortensen, Jann
AU - Kjær, Andreas
AU - Knigge, Ulrich
PY - 2010/10/25
Y1 - 2010/10/25
N2 - The prognosis of neuroendocrine tumours of the gastrointestinal tract and pancreas is difficult to estimate due to their heterogeneous nature. Survival without dissemination may reach 90%, while metastases reduce the 5-year survival to less than 50%. Radical surgery offers the only possibility of cure. Palliative therapy includes surgery and intra-arterial embolization of hepatic metastases, chemotherapy, biotherapy with interferon-alpha and radionuclear treatment. Tumour-targeted therapy with tyrosine kinase inhibitors, mammalian target of rapamycin inhibitors or monoclonal antibodies are under investigation in phase-III studies.
AB - The prognosis of neuroendocrine tumours of the gastrointestinal tract and pancreas is difficult to estimate due to their heterogeneous nature. Survival without dissemination may reach 90%, while metastases reduce the 5-year survival to less than 50%. Radical surgery offers the only possibility of cure. Palliative therapy includes surgery and intra-arterial embolization of hepatic metastases, chemotherapy, biotherapy with interferon-alpha and radionuclear treatment. Tumour-targeted therapy with tyrosine kinase inhibitors, mammalian target of rapamycin inhibitors or monoclonal antibodies are under investigation in phase-III studies.
M3 - Tidsskriftartikel
VL - 172
SP - 2942
EP - 2945
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
SN - 0041-5782
IS - 43
ER -
ID: 34052471